Listing of Advicenne on Euronext 

Dr. Luc-André Granier, CEO and co-founder of Advicenne, open the trading day in Paris.

Advicenne specializes in the research and development of drugs for the treatment of neglected neurological and nephrological diseases, mostly among children.